Camurus faces USFDA rejection on Acromegaly drug CAM2029 MD Bureau23 Oct 2024 4:21 PM ISTThe FDA's decision could delay the approval and subsequent launch of the drug, CAM2029, meant to treat patients with acromegaly.
Personalized Acromegaly Treatment Approach Yields Faster Hormonal Control: ACROFAST study Medha Baranwal18 July 2024 8:00 PM ISTSpain: The prospective ACROFAST trial indicated that a tailored treatment protocol was more effective for managing acromegaly, also known as...
Paltusotine found safe, effective among patients with acromegaly in phase 3 trial Jacinthlyn Sylvia14 Sept 2023 10:15 AM ISTA daily oral investigational drug has shown a significant ability to help patients with acromegaly maintain their insulin-like growth factor (IGF-1)...
Concomitant type 2 diabetes increases mortality and morbidity risk in acromegaly patients Dr. Hiral patel5 Aug 2022 10:00 AM ISTSweden: Coexistence of diabetes increases the risk of overall mortality as well as cardiovascular mortality and morbidity in patients with acromegaly,...
High prevalence of vertebral fractures seen in patients with acromegaly: Study Medha Baranwal10 May 2022 8:15 PM ISTItaly: The researchers in a recent study, have reported for the first time a high prevalence of radiological vertebral fractures (VFs) in patients...
Oral octreotide as good as injectable somatostatin receptor ligands for acromegaly treatment: Lancet Medical Dialogues Editorial Team27 Jan 2022 8:30 AM ISTMoscow, Russia: New research found that oral octreotide was not inferior to injectable somatostatin receptor ligands (iSRLs) medication and may be a...
Acromegaly patients at increased risk for cardiovascular diseases: European Heart Journal Medical Dialogues Editorial Team25 Dec 2021 9:00 AM ISTRepublic of Korea: Acromegaly patients were shown to be at increased risk for atrial fibrillation, congestive heart failure, and all-cause mortality...
FDA approves first and only oral treatment of Acromegaly Dr. Kamal Kant Kohli27 Jun 2020 9:23 AM ISTThe US Food and drug administration has approved first and only oral somatostatin analog octreotide as a long-term maintenance therapy for people...
New oral drug safe, effective treatment option for acromegaly patients Hina Zahid1 April 2020 3:12 PM ISTWASHINGTON--Researchers have found that an investigational oral form of the drug octreotide is an effective alternative to monthly injections of a...
